Patrick Lin - 17 May 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Reporting relationship: Chief Business - Strategy Off
Issuer ticker: PCSA
Reported as of: 17 May 2022
Net transaction value: +$3,189
SEC form: 4
Accepted by SEC: 19 May 2022, 18:11:43 UTC
Prior SEC filing: 08 Apr 2022
Next SEC filing: 05 Jul 2022
Source filing: View source filing
Reporting owner signature: /s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact

Key filing fact

Patrick Lin filed Form 4 for Processa Pharmaceuticals, Inc. (PCSA) on 19 May 2022.

Key facts

This page summarizes Patrick Lin's Form 4 filing for Processa Pharmaceuticals, Inc. (PCSA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2022, 18:11.

Change

Previous filing in this sequence was filed on 08 Apr 2022.
Current net transaction value: +$3,189.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCSA transaction

Common Stock

Purchase

Transaction value: $3,189
Shares: +2,000
Change %: +0.46%
Price: $1.59
Shares after: 433,390
Date: 17 May 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.53 to $1.77, inclusive. The Reporting Person undertakes to provide, Processa Pharmaceuticals, Inc. (the "Company") any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.